Cytomegalovirus Antibodies and Antigens

We are pleased to announce the expansion of our Cytomegalovirus (CMV) product range. New antibodies are now available to a variety of CMV antigens, to complement our ever-growing recombinant and native antigen range. Over half of the US population is infected with CMV by age 40. While most congenital CMV infections are asymptomatic, this virus poses a risk for unborn babies and those with a weakened immune system – and in some cases can be fatal. Pregnant women with an active CMV infection can pass the virus to their fetuses, and up to 20% of infected babies develop severe mental and physical disabilities including hearing loss, blindness, learning difficulties and epilepsy, which represent a significant burden to healthcare systems. United States Biological is committed to supporting ongoing research into CMV, providing reagents for use in accurate diagnostics and the development of an effective vaccine.

We now offer highly-specific antibodies to CMV glycoproteins, phosphoproteins, late protein and the pentamer complex. Our antibodies are high in purity and quality –suitable for rapid, accurate and reliable diagnostic tests, including ELISAs, Western blots and the development of LFDs.
We provide both native CMV antigens and highly-purified recombinant antigens, expressed in our mammalian cell system. These include CMV pentamer complex, glycoproteins, whole virus and cell lysate. Our high-quality antigens are suitable for both IVD assay development and vaccine R&D.